News
With its existing entitlement, plus the newly acquired economics from BioInvent, XOMA Royalty will be entitled to milestones of up to USD $16.25 million from Takeda and mid-single digit royalties on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback